project id: TCGA-BLCA; case submitter id: TCGA-DK-AA6W; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.94; rna integrity number: 7.6; age at index: 78; days to birth: -28853; days to death: 415; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1935; age at diagnosis: 28853; ajcc clinical t: T2; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 263.0; icd 10 code: C67.2; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lateral wall of bladder; synchronous malignancy: Not Reported; tissue or organ of origin: Lateral wall of bladder; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; weight: 20.0; composition: Not Reported; days to collection: 68; initial weight: 80.0; sample id: e6db8232-33b3-4449-a2fc-cde3b7d3d72b; sample submitter id: TCGA-DK-AA6W-01A; portion id: 0ceb6f14-e73b-4fff-819f-d049833ba40c; portion submitter id: TCGA-DK-AA6W-01A-12; slide id: 6f47819d-7fd6-459a-a345-4414af431585; slide submitter id: TCGA-DK-AA6W-01A-01-TS1; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 65.0; section location: TOP;